Apex Labs Ltd.

We are thrilled to announce that in collaboration with Apex Labs Ltd. Yale School of Medicine intends to conduct a pharmacokinetics and driving simulator study of microdose psilocybin at our world-class DrivSim Lab’s DSRI miniSim™ Research Driving Simulator.  🌟 This research is key for the development of APEX-52 take home microdose psilocybin and growing our understanding of how novel psychedelic treatments can impact patient’s lives. Learn more here: https://lnkd.in/gxKFhEav #Yale #PsilocybinResearch #MentalHealthInnovation #DrivingSimulation

APEX has filed an IND application with the U.S. Food and Drug Administration (FDA) for a groundbreaking study at Yale School of Medicine. This 55-patient study will explore the pharmacokinetics and effects of microdose psilocybin on driving performance using Yale's state-of-the-art DrivSim Lab to determine when it's safe for patients to drive after dosing. Learn more here: https://lnkd.in/gxKFhEav #Yale #PsilocybinResearch #MentalHealthInnovation #DrivingSimulation

APEX was featured by CBC, highlighting the upcoming launch of our 160 patient SUMMIT-90 clinical trial evaluating APEX-90 alongside assisted psychotherapy. Current sites in #London, #Montreal, #Toronto, and #Halifax will recruit patients once the trial launches, with pre-screening underway at ptsdresearch.ca. Great article by Alessio Donnini. #Psilocybin #PTSD #Biotech #ClinicalResearch #Psychedelics #CBC https://lnkd.in/gAATMPvD

Exciting news! APEX filed a US patent protecting our uniquely formulated capsule, improving stability and bioavailability for psilocybin and other psychedelics and paving the way for strong and sustainable commercial sales. Read more here: https://prn.to/3TqJzia #HealthcareInnovation #MentalHealth #PsychedelicResearch #VeteransHealth #Psilocybin #Psychedelics

APEX has received its Dealers Licence from Health Canada allowing direct psilocybin sales through multiple channels, paving the way to both access and revenue in Canada. Learn more here: https://bit.ly/3wla0wQ #HealthcareInnovation #MentalHealth #PsychedelicResearch #VeteransHealth #Psilocybin

Another signal of growing support from US regulators towards access to psilocybin therapies state after state! #HealthcareInnovation #MentalHealth #PsychedelicResearch #Psilocybin

US Veterans Affairs (VA) will fund research into psilocybin and MDMA for treating PTSD and depression! As a Veteran focused company, we applaud the VA for this huge milestone and step forward towards broader access. #HealthcareInnovation #MentalHealth #PsychedelicResearch #VeteransHealth #Psilocybin https://bit.ly/3HaaLuG

Coinciding with the launch of a special edition of the JMVFH - The Journal of Military, Veteran and Family Health, I have an article in The Conversation Canada calling for new mental health tools for Canadian Veterans, with some thoughts on how to shape a new psychedelics research framework. An important time in Canadian health policy and Veteran health. Public investment in psychedelic science at this time in this way could really improve our understanding of psychedelic-assisted therapies, how they work, safety considerations and program/policy considerations. Important to get this right, and do this well, which will mean collaboration between researchers, stakeholders such as Heroic Hearts Project Canada, policy-makers, clinicians and health program providers and will include significant knowledge translation and implementation science components. I suggest CIMVHR - Canadian Institute for Military and Veteran Health Research can play a critical role in developing what comes next. I was fortunate to feature in the article a photo of my father -- then Corporal John (Jack) William Shore -- from 1964 as his regiment was leaving their UN Peacekeeping mission in The Congo. While he holds a brave face, as a 24-year old young man he had witnessed horrendous trauma, violence and suffering and received no supports to address his moral injury and what we now understand as PTSD. That experience left an indelible mark on my father and our family as we grew. We owe our service members, Veterans and their families better. It took Dad decades to come to terms with the impact; he would become a certified Grief Counsellor after his retirement from the military and became the kindest man I have known. But it was a real journey, one that continues to unfold for me, my siblings and our families. #psychedelicresearch #psychedelictherapy #veterans #moralinjury #ptsd #mentalhealth https://lnkd.in/gRzh9xUT

A recent article highlights growing momentum in US Congress supporting exploring psychedelic treatments for PTSD among military servicemembers and Veterans. This shift in attitude marks another significant step towards integrating therapies like psilocybin into mainstream healthcare. Current legislative efforts include potential studies by the Defense Department, spearheaded by advocates like Reps. Alexandria Ocasio-Cortez and Daniel Crenshaw. Read more about this pivotal moment here: https://bit.ly/3Gk2O5E #psychedelics #mentalhealth #Veterans #PTSD #biotech #healthcareinnovation #clinicaltrials

The Canadian Senate Subcommittee on Veterans Affairs called for research in and expanded access to psychedelic-assisted therapy, mentioning APEX’s work. Read this deep-dive POV from our Chief Medical Officer Dr. Mark Johnston, MD, FRCP(C) and Chief Strategy Officer Arron Victory breaking down their new report and sharing key recommendations on moving forward.👇 #Psychedelics #cdnpoli #Veterans #mentalhealth #pharma #ptsd #Canada